Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A2YNT30
Fri, 07.05.2021
AlzChem Group AG
AlzChem Group AG
Disclosure
according to Article 5 of the EU Regulation 596/2014
and Article 2 Section (1) of the Delegated EU Regulation 2016/10528th Interim report
In the period from May 3, 2021 up to and including May 7, 2021, a total of 1.747 shares of AlzChem Group AG were acquired as part of the share buyback program announced on February 2, [ … ]
Thu, 06.05.2021
AlzChem Group AG
AlzChem Group AG achieves record Q1 sales
Highest Q1 sales in the company's history of EUR 104.3 million (+10.1%)
Strong EBITDA growth of 35.8% to EUR 16.7 million
Consolidated result rises significantly by 79.3% to EUR 7.9 million
Outlook 2021: Sales and EBITDA expected at upper end of forecast
Trostberg, May 6, 2021 - AlzChem Group AG, a ver [ … ]
Mon, 03.05.2021
AlzChem Group AG
AlzChem Group AG
Disclosure
according to Article 5 of the EU Regulation 596/2014
and Article 2 Section (1) of the Delegated EU Regulation 2016/10527th Interim report
In the period from April 26, 2021 up to and including April 30, 2021, a total of 3.091 shares of AlzChem Group AG were acquired as part of the share buyback program announced on Febru [ … ]
Mon, 26.04.2021
AlzChem Group AG
AlzChem Group AG
Disclosure
according to Article 5 of the EU Regulation 596/2014
and Article 2 Section (1) of the Delegated EU Regulation 2016/10526th Interim report
In the period from April 19, 2021 up to and including April 23, 2021, a total of 1.708 shares of AlzChem Group AG were acquired as part of the share buyback program announced on Febru [ … ]
Mon, 12.04.2021
AlzChem Group AG
AlzChem Group AG
Disclosure
according to Article 5 of the EU Regulation 596/2014
and Article 2 Section (1) of the Delegated EU Regulation 2016/10525th Interim report
In the period from April 5, 2021 up to and including April 9, 2021, a total of 1.200 shares of AlzChem Group AG were acquired as part of the share buyback program announced on Februar [ … ]
Fri, 22.01.2021
AlzChem Group AG
DGAP-Media / 22.01.2021 / 13:48
AlzChem, the leading manufacturer of high-quality creatine monohydrate, has successfully presented in a voluntary GRAS notification that the use of its self-manufactured creatine monohydrate under the Creapure(R) brand in food is safe. GRAS stands for "Generally Recognized As Safe". The conclusion is based on [ … ]
Wed, 11.11.2020
AlzChem Group AG
Trostberg, November 11, 2020 - AlzChem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, generated consolidated sales of EUR 278.6 million in the first nine months of fiscal year 2020, compared to EUR 287.7 million in the 9-month period of 2019. The slight growth in the Specialt [ … ]
Thu, 05.11.2020
AlzChem Group AG
Trostberg, November 5, 2020 - AlzChem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, consistently continues its growth and investment strategy even in the current environment. Due to the continuing high level of market demand, nitrile production will be expanded by up to 50% [ … ]
Tue, 11.08.2020
AlzChem Group AG
AlzChem Group AG: Sales and EBITDA develop in line with the forecast in the first half of 2020
Sales increase by 4.8% to EUR 197.3 million
EBITDA grows by 4.6% to EUR 29.1 million
Extraordinary demand for Bioselect(R) as an important component of COVID-19 test kits
Forecast 2020 confirmed: target corridor is reached at the lower end due to U i [ … ]